tiprankstipranks
Trending News
More News >
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
US Market
Advertisement

Royalty Pharma (RPRX) Technical Analysis

Compare
1,275 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
4Neutral
11Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Royalty Pharma PLC’s (RPRX) Moving Averages Convergence Divergence (MACD) indicator is -0.21, suggesting Royalty Pharma PLC is a Buy.
Royalty Pharma PLC’s (RPRX) 20-Day exponential moving average is 35.84, while Royalty Pharma PLC’s (RPRX) share price is $35.04, making it a Sell.
Royalty Pharma PLC’s (RPRX) 50-Day exponential moving average is 35.82, while Royalty Pharma PLC’s (RPRX) share price is $35.04, making it a Sell.

Royalty Pharma (RPRX) Pivot Points

Sep 29, 2025, 05:02 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
33.22
34.00
34.45
35.22
35.67
36.45
36.90
Fibonacci
34.00
34.46
34.75
35.22
35.69
35.98
36.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Royalty Pharma (RPRX) Moving Averages

Sep 29, 2025, 05:02 PM
Period
Simple
Exponential
MA5
35.56Sell
35.40Sell
MA10
35.60Sell
35.63Sell
MA20
35.97Sell
35.84Sell
MA50
36.22Sell
35.82Sell
MA100
35.15Sell
34.95Buy
MA200
32.70Buy
32.57Buy
Royalty Pharma PLC’s (RPRX) 10-Day exponential moving average is 35.63, while Royalty Pharma PLC’s (RPRX) share price is $35.04, making it a Sell.
Royalty Pharma PLC’s (RPRX) 100-Day exponential moving average is 34.95, while Royalty Pharma PLC’s (RPRX) share price is $35.04, making it a Buy.
Royalty Pharma PLC’s (RPRX) stock price is $35.04 and Royalty Pharma PLC’s (RPRX) 50-day simple moving average is 36.22, creating a Sell signal.
Royalty Pharma PLC’s (RPRX) stock price is $35.04 and Royalty Pharma PLC’s (RPRX) 100-day simple moving average is 35.15, creating a Sell signal.
Royalty Pharma PLC’s (RPRX) stock price is $35.04 and Royalty Pharma PLC’s (RPRX) 200-day simple moving average is 32.70, creating a Buy signal.

Royalty Pharma (RPRX) Technical Indicators

Sep 29, 2025, 05:02 PM
Name
Value
Implied Action
RSI (14)
42.04
Neutral
STOCH (9,6)
24.55
Neutral
STOCHRSI (14)
33.10
Neutral
MACD (12,26)
-0.21
Buy
ADX (14)
15.00
Buy
Williams %R
-82.25
Buy
CCI (14)
-149.70
Buy
ATR (14)
0.85
-
Ultimate Oscillator
45.59
Neutral
ROC
-2.12
Sell
Royalty Pharma PLC’s (RPRX) Relative Strength Index (RSI) is 42.04, creating a Neutral signal.
Royalty Pharma PLC’s (RPRX) Trend Strength Indicator (ADX) is 15.00, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) Commodity Channel Index (CCI) is -149.70, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) Price Rate of Change (ROC) is -2.12, creating a Sell signal.

FAQ

Is RPRX a Buy, Hold, or Sell?
Based on RPRX’s technical indicators, RPRX is a Sell.
    What is RPRX’s RSI (14)?
    RPRX’s RSI (14) is 42.04, which suggests RPRX is a Neutral.
      What is RPRX’s MACD?
      RPRX’s MACD is -0.21, which suggests RPRX is a Buy.
        What is RPRX’s 5-day moving average?
        RPRX’s 5-day moving average is 35.56, which suggests RPRX is a Sell.
          What is RPRX’s 20-day moving average?
          RPRX 20-day moving average is 35.97, which suggests RPRX is a Sell.
            What is RPRX’s 50-day moving average?
            RPRX’s 50-day moving average is 36.22, which suggests RPRX is a Sell.
              What is RPRX’s 200-day moving average?
              RPRX’s 200-day moving average is 32.70, which suggests RPRX is a Buy.
                What is RPRX’s Williams % R (14)?
                RPRX’s Williams % R (14) is -82.25, which suggests RPRX is a Buy.
                  What is RPRX’s CCI (14)?
                  RPRX’s CCI (14) is -149.70, which suggests RPRX is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis